Follow
Amirhossein Modabbernia, MD, PhD, Assistant Professor of Psychiatry
Amirhossein Modabbernia, MD, PhD, Assistant Professor of Psychiatry
Department of Psychiatry, Mount Sinai School of Medicine
Verified email at mssm.edu
Title
Cited by
Cited by
Year
Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses
A Modabbernia, E Velthorst, A Reichenberg
Molecular autism 8, 1-16, 2017
8012017
Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies
A Modabbernia, S Taslimi, E Brietzke, M Ashrafi
Biological psychiatry 74 (1), 15-25, 2013
6472013
Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study
SH Abbasi, F Hosseini, A Modabbernia, M Ashrafi, S Akhondzadeh
Journal of affective disorders 141 (2-3), 308-314, 2012
3582012
Laughter yoga versus group exercise program in elderly depressed women: a randomized controlled trial
M Shahidi, A Mojtahed, A Modabbernia, M Mojtahed, A Shafiabady, ...
International journal of geriatric psychiatry 26 (3), 322-327, 2011
3182011
Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial
A Modabbernia, H Sohrabi, AA Nasehi, F Raisi, S Saroukhani, A Jamshidi, ...
Psychopharmacology 223, 381-388, 2012
2002012
Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3–90 years
S Frangou, A Modabbernia, SCR Williams, E Papachristou, GE Doucet, ...
Human brain mapping 43 (1), 431-451, 2022
1762022
Saffron for treatment of fluoxetine‐induced sexual dysfunction in women: randomized double‐blind placebo‐controlled study
L Kashani, F Raisi, S Saroukhani, H Sohrabi, A Modabbernia, AA Nasehi, ...
Human Psychopharmacology: Clinical and Experimental 28 (1), 54-60, 2013
1702013
Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study
A Ghaleiha, N Entezari, A Modabbernia, B Najand, N Askari, M Tabrizi, ...
Journal of psychiatric research 47 (2), 175-180, 2013
1672013
Natural history of cavernous malformation: systematic review and meta-analysis of 25 studies
S Taslimi, A Modabbernia, S Amin-Hanjani, FG Barker, RL Macdonald
Neurology 86 (21), 1984-1991, 2016
1612016
Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial
K Sepanjnia, A Modabbernia, M Ashrafi, MJ Modabbernia, ...
Neuropsychopharmacology 37 (9), 2093-2100, 2012
1552012
Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
M Asadabadi, MR Mohammadi, A Ghanizadeh, A Modabbernia, M Ashrafi, ...
Psychopharmacology 225, 51-59, 2013
1312013
Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia: an 8-week, randomized, double-blind, placebo-controlled study
A Modabbernia, F Rezaei, B Salehi, M Jafarinia, M Ashrafi, M Tabrizi, ...
CNS drugs 27, 57-65, 2013
1272013
Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome …
L Kashani, T Omidvar, B Farazmand, A Modabbernia, F Ramzanzadeh, ...
Psychoneuroendocrinology 38 (6), 767-776, 2013
1242013
Melatonin for prevention of metabolic side-effects of olanzapine in patients with first-episode schizophrenia: randomized double-blind placebo-controlled study
A Modabbernia, P Heidari, R Soleimani, A Sobhani, ZA Roshan, S Taslimi, ...
Journal of psychiatric research 53, 133-140, 2014
1142014
Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania
Z Amrollahi, F Rezaei, B Salehi, AH Modabbernia, A Maroufi, ...
Journal of affective disorders 129 (1-3), 327-331, 2011
1132011
Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study
MR Khodaie-Ardakani, O Mirshafiee, M Farokhnia, M Tajdini, ...
Psychiatry research 215 (3), 540-546, 2014
1082014
Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study
D Khajavi, M Farokhnia, A Modabbernia, M Ashrafi, SH Abbasi, M Tabrizi, ...
Journal of Clinical Psychiatry 73 (11), 1428, 2012
1062012
Subcortical volumes across the lifespan: Data from 18,605 healthy individuals aged 3–90 years
D Dima, A Modabbernia, E Papachristou, GE Doucet, I Agartz, M Aghajani, ...
Human brain mapping 43 (1), 452-469, 2022
922022
Impaired gas exchange at birth and risk of intellectual disability and autism: a meta-analysis
A Modabbernia, J Mollon, P Boffetta, A Reichenberg
Journal of autism and developmental disorders 46, 1847-1859, 2016
792016
Granisetron adjunct to fluvoxamine for moderate to severe obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial
N Askari, M Moin, M Sanati, M Tajdini, SMR Hosseini, A Modabbernia, ...
CNS drugs 26, 883-892, 2012
782012
The system can't perform the operation now. Try again later.
Articles 1–20